With 80% of today’s cancer drugs reaching the US market under the FDA’s accelerated approval pathway,1 …
FDA
-
-
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ …
-
Patients with atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) who were prescribed a combination of …
-
Health
FDA Panel Rejects Belantamab Mafodotin Combinations for Multiple Myeloma, Citing Safety Concerns
Belantamab mafodotin’s (Blenrep; GSK) return to the US market hit a significant hurdle as the FDA’s …
-
The American Academy of Sleep Medicine has indicated that an estimated 26 percent of adults between …
-
Abroticinib is a JAK inhibitor approved by the FDA in 2022 for the treatment of adults …
-
WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring …
-
“`html FDA Expands Approval of Moderna‘s RSV Vaccine to Younger Adults | health News Daily FDA …
-
“`html FDA Expands Meningococcal Vaccine Indication to Include Infants Table of Contents FDA Expands Meningococcal Vaccine …
-
“`html FDA Approves New Eye Drop for Dry Eye Disease Table of Contents FDA Approves New …
